RAS inhibitors, beta-blockers after discharge improve outcomes in MI with mid-range EF: Study
South Korea: The medical therapy with beta-blockers or RAS inhibitors at discharge is tied to better 2-year clinical outcomes in patients with mildly reduced left ventricular ejection fraction (EF)...
Source: medicaldialogues.in